Prog Lipid Res 41, 392406.CrossRefGoogle ScholarPubMed Perego, P, Paolicchi, A, Tongiani, R, et al
Contact Customer service and products Contact us Career Email us Investor relations Email us Press and media relations Email us Website and digital communication Email us
What youll learn: Orforglipron is an oral GLP-1 medication in clinical trials that offers weight loss benefits without the need for injections
Weight maintenance requires ongoing effort through either continued medication at lower doses or strict adherence to lifestyle modifications
A healthcare professional can review a patients medical history, existing conditions, and current medications before making recommendations
There have been reports of acute kidney injury and worsening chronic renal failure in patients taking GLP-1 receptor agonists, including Semaglutide